<DOC>
	<DOC>NCT01788501</DOC>
	<brief_summary>This study aims to compare efficacy and safety of tacrolimus/methotrexate with cyclosporine/methotrexate for graft versus host disease prophylaxis in paediatric allogeneic hematopoietic stem cell transplantation patients.</brief_summary>
	<brief_title>Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft vs Host Disease</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Cyclosporine</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Cyclosporins</mesh_term>
	<criteria>Diagnosis of hematological malignancy Age under 18 years old Serum bilirubin less than 1.5 X upper limit of normal Aspartate transaminase, Alanine transaminase less than 2.5 X upper limit of normal Alkaline phosphatase less than 2.5 X upper limit of normal Serum creatinine less than 1.5 X upper limit of normal Agrees to participate, and informed consent signed Evidence of HIV infection Documented uncontrolled disease (infections) Prior transplantation (hematopoietic stem cell or solid organs)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>